menu search

Nio stock spiking higher as et5 prototypes roll off assembly line just 2 months after launch

One of the key catalysts that can lift Nio Inc's (NYSE: NIO) stock from its doldrums is the ramping up of the ET5, the EV maker's newest model unve...

January 31, 2022, 12:07 pm

Nio stock spiking higher as et5 prototypes roll off assembly line just 2 months after launch

One of the key catalysts that can lift Nio Inc's (NYSE: NIO) stock from its doldrums is the ramping up of the ET5, the EV maker's newest model unve...

January 31, 2022, 12:07 pm

F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers

The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned ...

January 27, 2022, 7:29 am

F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers

The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned ...

January 27, 2022, 7:29 am

F-star therapeutics: best-in-class tetravalent bispecific antibody technology in cancers

The company's unique selling proposition is its novel, tetravalent bispecific antibody platform which has earned ...

January 27, 2022, 7:29 am

Cobalt blue attends landmark talks with korean president to discuss ethical supply of cobalt

Cobalt Blue Holdings Ltd (ASX:COB, OTC:CBBHF) has received strong validation of its strategy to supply ...

December 14, 2021, 11:37 pm

Cobalt blue attends landmark talks with korean president to discuss ethical supply of cobalt

Cobalt Blue Holdings Ltd (ASX:COB, OTC:CBBHF) has received strong validation of its strategy to supply ...

December 14, 2021, 11:37 pm

Cobalt blue attends landmark talks with korean president to discuss ethical supply of cobalt

Cobalt Blue Holdings Ltd (ASX:COB, OTC:CBBHF) has received strong validation of its strategy to supply ...

December 14, 2021, 11:37 pm

Gbs shares are rallying on plans for covid-19 antibody trials after validation study

GBS Inc (NASDAQ:GBS) will prepare for clinical trials of its rapid SARS-CoV-2 (COVID-19) Antibody test following the recent successful completion o...

November 30, 2021, 1:11 pm

Gbs shares are rallying on plans for covid-19 antibody trials after validation study

GBS Inc (NASDAQ:GBS) will prepare for clinical trials of its rapid SARS-CoV-2 (COVID-19) Antibody test following the recent successful completion o...

November 30, 2021, 1:11 pm

Gbs shares are rallying on plans for covid-19 antibody trials after validation study

GBS Inc (NASDAQ:GBS) will prepare for clinical trials of its rapid SARS-CoV-2 (COVID-19) Antibody test following the recent successful completion o...

November 30, 2021, 1:11 pm

Sesen bio: hoping for an easy revalidation of vicineum by 2022

The US FDA published the warning letter on October 27, 2021, just 2 days before CMC Type A meeting with Sesen Bio. The move informed its rejection of ...

November 16, 2021, 9:11 pm

Sesen bio: hoping for an easy revalidation of vicineum by 2022

The US FDA published the warning letter on October 27, 2021, just 2 days before CMC Type A meeting with Sesen Bio. The move informed its rejection of ...

November 16, 2021, 9:11 pm

Sesen bio: hoping for an easy revalidation of vicineum by 2022

The US FDA published the warning letter on October 27, 2021, just 2 days before CMC Type A meeting with Sesen Bio. The move informed its rejection of ...

November 16, 2021, 9:11 pm

Davita climate action goals approved by the science based target initiative

DENVER, Oct. 11, 2021 /PRNewswire/ -- DaVita furthers commitment to climate action goals with validation...

October 11, 2021, 6:02 am

Davita climate action goals approved by the science based target initiative

DENVER, Oct. 11, 2021 /PRNewswire/ -- DaVita furthers commitment to climate action goals with validation...

October 11, 2021, 6:02 am

Davita climate action goals approved by the science based target initiative

DENVER, Oct. 11, 2021 /PRNewswire/ -- DaVita furthers commitment to climate action goals with validation...

October 11, 2021, 6:02 am

Todos medical unveils positive clinical validation data for its 3cl protease biomarker assay tollotest in a clinical study of covid-19 patients

Todos Medical Ltd. has announced positive clinical validation data for its 3CL protease biomarker assay...

October 6, 2021, 11:26 am

Todos medical unveils positive clinical validation data for its 3cl protease biomarker assay tollotest in a clinical study of covid-19 patients

Todos Medical Ltd. has announced positive clinical validation data for its 3CL protease biomarker assay...

October 6, 2021, 11:26 am

Todos medical unveils positive clinical validation data for its 3cl protease biomarker assay tollotest in a clinical study of covid-19 patients

Todos Medical Ltd. has announced positive clinical validation data for its 3CL protease biomarker assay...

October 6, 2021, 11:26 am


Search within

Pages Search Results: